Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/26 17:25 | 8/7/26 | BRVE | Health | Drug | Pharmaceutical Preparations | Forbion Growth Opportunities Fund III Cooperatief U.A. | T | 1 | P.d | 64,800 | 18.00 | 0 | 3,600 | 20 | 21,826 | M | ||||||||||||||||
8/7/26 16:41 | 8/7/26 | BRVE | Health | Drug | Pharmaceutical Preparations | Rickey James Paul | CA | O | CFO | 1 | P.d | 500 | 18.00 | 0 | 28 | 4 | 704 | D | ||||||||||||||
8/7/26 16:31 | 8/7/26 | BRVE | Health | Drug | Pharmaceutical Preparations | Viehbacher Christopher | CA | D | 1 | P.d | 1,500 | 18.00 | 0 | 83 | 12 | 760 | D | |||||||||||||||
8/7/26 16:31 | 8/7/26 | BRVE | Health | Drug | Pharmaceutical Preparations | Malek David I | CA | D | 1 | P.d | 75 | 18.00 | 0 | 4 | 0 | 1,013 | D | |||||||||||||||
8/7/26 16:30 | 8/7/26 | BRVE | Health | Drug | Pharmaceutical Preparations | Anderson Michele A. | CA | O | Chief De | 1 | P.d | 20 | 18.00 | 0 | 1 | 0 | 332 | D | ||||||||||||||
8/7/26 16:30 | 8/7/26 | BRVE | Health | Drug | Pharmaceutical Preparations | Murdoch Travis | CA | DO | CEO,P | 1 | P.d | 1,500 | 18.00 | 0 | 83 | 1 | 8,334 | D | ||||||||||||||
8/7/26 16:30 | 8/7/26 | BRVE | Health | Drug | Pharmaceutical Preparations | Lubner David Charles | CA | D | 1 | P.d | 1,000 | 18.00 | 0 | 56 | 56 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |